Skip to content
Search

Latest Stories

Collaborative working key to successful launch of EPS in Wales

Collaborative working key to successful launch of EPS in Wales

The new EPS service is currently in a live testing phase, with a phased roll out across Wales expected from January 2024.

The Digital Medicines Transformation Portfolio (DMTP) was able to deliver the electronic prescription service (EPS) in Wales - just 20 months after starting the project - with support from key partners in the NHS and industry.


Patients in Rhyl were the first to benefit from the new service, which allows GPs to send prescriptions electronically to the patient’s choice of community pharmacy, without the need for a paper form.

The new EPS service is currently in a live testing phase, with a phased roll out across Wales expected from January 2024.

DMTP, which is hosted by Digital Health and Care Wales (DHCW) has worked closely with NHS England, who provided the core EPS platform that has been developed for use in Wales. NHS Wales Shared Services Partnership has also made a major contribution in the project, incorporating digital reimbursement to pharmacies and putting security measures in place.

Fintan Grant, NHSE’s Deputy Director of Digital Delivery for Digital Medicines, said: “NHS England is proud to work with Digital Health and Care Wales to ensure the benefits of using the Electronic Prescription Service can be realised by patients and frontline NHS colleagues across Wales.

“The first go-live is always a major milestone and follows significant effort, ambition and will from a number of organisations, teams and third party suppliers. I congratulate all involved with this first step in the rollout.”

The EPS project has involved working closely with 16 suppliers of pharmacy and GP IT systems, with each supplier required to modify their systems to be able to send and receive electronic prescriptions securely.

To support this and other innovations, DMTP teamed up with Life Sciences Hub Wales and established the Community Pharmacy System Innovation Fund, to provide grants to suppliers of community pharmacy systems.

Cari-Anne Quinn, CEO at Life Sciences Hub Wales, said: “It’s fantastic that electronic prescription services are now directly benefitting people in Wales thanks to ongoing work including the Community Pharmacy System Innovation Fund.

“Life Sciences Hub Wales has worked in partnership with DMTP - with our organisation managing the Fund and award process – helping suppliers of community pharmacy systems to develop their systems to use electronic prescription services.”

Invatech Health’s Titan pharmacy system and EMIS GP system supplier are the first to get their systems ready to go live with EPS in Wales.

Invatech Health CEO, Tariq Muhammad said: “This is a really important milestone in our journey to support the advance of health services in Wales. We are so pleased to play our part in helping bring this technology to Wales and are looking forward to making this available to the whole of Wales to benefit patients, pharmacists, and doctors alike.”

Dr Shaun O’Hanlon, Chief Medical Officer of EMIS Group, commented: “We are absolutely delighted to have been able to support the Welsh Government’s commitment to digitalise prescriptions with our technology. We’ve worked closely with the teams at Digital Medicines Transformation Portfolio to implement the new electronic prescription service and we’re delighted to hear from practice staff and patients alike that the new service is already starting to save time and provide a better service for patients.

“The project also includes tech to support further development and the introduction of smartcards for Wales too, which represents a big step in the digitisation programme.”

The DMTP aims to make the prescribing, dispensing and administration of medicines, easier, safer, more efficient and effective for patients and professionals through digital.

Professor Hamish Laing, Senior Responsible Owner for the DMTP, said: “Our collaborative approach, placing people at the centre and working closely with clinicians, patients and industry suppliers ensures we are delivering a service that meets the needs of all who use it.”

Not only the EPS service will benefit patients, GP surgeries and pharmacies, but it will help protect the environment, by saving up to 40 million paper forms from being printed each year.

The EPS project is one part of a wider commitment by Welsh Government to introduce digital medicines and e-prescribing in all hospitals and primary care in Wales, through the DMTP.

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less